(Q37727987)

22 August 2017

1 reference

title

Diagnostic use of autoantibodies in myasthenia gravis (English)

1 reference

22 August 2017

0 references

0 references

1 reference

3

Angela Vincent

1 reference

22 August 2017

M Isabel Leite

1

1 reference

22 August 2017

Patrick Waters

series ordinal

2

1 reference

22 August 2017

publication date

1 August 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

43

1 reference

22 August 2017

issue

5-6

1 reference

22 August 2017

page(s)

371-379

1 reference

Striational antibodies in myasthenia gravis: reactivity and possible clinical significance

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Myasthenia gravis: measurement of anti-AChR autoantibodies using cell line TE671.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Anti-acetylcholine receptor (AChR) antibodies measurement in myasthenia gravis: the use of cell line TE671 as a source of AChR antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the epsilon subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

A transfected human muscle cell line expressing the adult subtype of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Frequency of anti-AChR epsilon subunit-specific antibodies in MG.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Autoimmune channelopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

A sensitive non-isotopic assay for acetylcholine receptor autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in 'antibody-negative' myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Muscle-specific receptor tyrosine kinase autoantibodies--a new immunoprecipitation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Antibodies in myasthenia gravis and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Autoimmune myasthenia gravis in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

The congenital myasthenic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Further observations in congenital myasthenic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Evidence of underdiagnosis of myasthenia gravis in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Thymus changes in anti-MuSK-positive and -negative myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Anti-MuSK antibodies: correlation with myasthenia gravis severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Muscle autoantibodies in subgroups of myasthenia gravis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Immunosuppressive therapies in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Seronegative Myasthenia Gravis: Evidence for Plasma Factor(s) Interfering with Acetylcholine Receptor Function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Novel autoantibodies to a voltage-gated potassium channel KV1.4 in a severe form of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

Classification of Myasthenia Gravis Based on Autoantibody Status

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903541208

10.3109/08916930903541208

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference